Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 15;11(12):e8284.
doi: 10.1002/ccr3.8284. eCollection 2023 Dec.

Transfusion-Related acute lung injury (TRALI) caused by antibodies to HLA-DRB1* 07:01 and HLA-DQB1*02:02: A case report

Menggentuya Huang  1 , Xingtong Wang  2 , Li Wang  1 , Guanyi Chen  1
Affiliations
Case Reports

Transfusion-Related acute lung injury (TRALI) caused by antibodies to HLA-DRB1* 07:01 and HLA-DQB1*02:02: A case report

Menggentuya Huang et al. Clin Case Rep. .

Abstract

Transfusion-related acute lung injury (TRALI) is characterized by non-cardiogenic pulmonary edema and acute hypoxemia. There are few reports of HLA-II antibodies causing TRALI in China.

Keywords: HLA class II antibodies; blood transfusion; pulmonary edema; transfusion‐related acute lung injury.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interests.

Figures

FIGURE 1
FIGURE 1
Lung images. (A) Chest X‐ray is taken approximately 1 h after transfusion showing bilateral lung infiltrates, bilateral pulmonary oedema, and cardiac shadow with standard size and normal morphology. (B) Chest computed tomography (CT) 22 days after transfusion showing obvious absorption of bilateral lung infiltrates.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2020. https://www.fda.gov/media/160859/download.
    1. Vlaar APJ, Toy P, Fung M, et al. A consensus redefinition of transfusion‐related acute lung injury. Transfusion. 2019;59(7):2465‐2476. doi:10.1111/trf.15311 - DOI - PMC - PubMed
    1. Politis C, Wiersum JC, Richardson C, et al. The international haemovigilance network database for the surveillance of adverse reactions and events in donors and recipients of blood components: technical issues and results. Vox Sang. 2016;111(4):409‐417. doi:10.1111/vox.12447 - DOI - PubMed
    1. Vlaar AP, Binnekade JM, Prins D, et al. Risk factors and outcome of transfusion‐related acute lung injury in the critically ill: a nested case‐control study. Crit Care Med. 2010;38(3):771‐778. doi:10.1097/CCM.0b013e3181cc4d4b - DOI - PubMed
    1. Reil A, Keller‐Stanislawski B, Günay S, Bux J. Specificities of leucocyte alloantibodies in transfusion‐related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313‐317. doi:10.1111/j.1423-0410.2008.01092.x - DOI - PubMed

Publication types